Tag: treatment for haemophilia B
CSL completes acquisition of novel gene therapy for haemophilia B
CSL Limited has wrapped up the acquisition of uniQure’s etranacogene dezaparvovec, a novel gene therapy for the treatment of haemophilia B.
Under the agreement, CSL...
Featured Article
Automotive canopy and tray manufacturer manages 6,000 SKUs with self-implemented ERP
Australian automotive accessories manufacturer Trig Point self-implemented an ERP system in just three months and gained control over its unwieldy component inventory, product customizations, and production processes. “We wouldn’t be able to manage that without a system like this,” says Chris Wasylkiw, Production Engineer.
